Article Information
History
- May 22, 2026.
Article Versions
- Version 1 (December 19, 2025 - 17:03).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tue Leth Nielsen1,
- Michelle Damgaard1,2,
- Nicoline Resen Andersen2,
- Morten Dunø3,
- Anja Lisbeth Frederiksen4,5,
- Gerrit van Hall2,6,
- Lykke Sylow2,
- Marta Murgia7,8,
- Steen Larsen2,9,
- Signe S. Torekov2,
- John Vissing1 and
- Matteo Fiorenza1,2,*
- 1Copenhagen Neuromuscular Center, Department of Neurology, Copenhagen University Hospital–Rigshospitalet, Copenhagen, Denmark
- 2Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
- 3Department of Clinical Genetics, Copenhagen University Hospital–Rigshospitalet, Copenhagen, Denmark
- 4Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
- 5Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark
- 6Clinical Integrative Fluxomics Core, Department of Clinical Biochemistry, Copenhagen University Hospital–Rigshospitalet, Copenhagen, Denmark
- 7Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Martinsried, Germany
- 8Department of Biomedical Sciences, University of Padua, Padua, Italy
- 9Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
- ↵*Correspondence: matteo.fiorenza{at}sund.ku.dk
Posted May 22, 2026.
An exercise-modifiable mitochondrial basis for skeletal muscle insulin resistance in humans
